Ausgabe 5/1997
Inhalt (13 Artikel)
Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors
Eric P. Sipos, Betty Tyler, Steven Piantadosi, Peter C. Burger, H. Brem
Antiestrogenic activity of DP-TAT-59, an active metabolite of TAT-59 against human breast cancer
T. Toko, Jiro Shibata, Mamoru Nukatsuka, Yuji Yamada
Potentiation of etoposide-induced apoptosis by staurosporine in human tumor cells is associated with events downstream of DNA-protein complex formation
Richard B. Lock, Bruce S. Thompson, Daniel M. Sullivan, Lolita Stribinskiene
Induction of apoptosis in multi-drug resistant (MDR) human glioblastoma cells by SN-38, a metabolite of the camptothecin derivative CPT-11
Shouji Nakatsu, S. Kondo, Yasuko Kondo, Dali Yin, John W. Peterson, Rami Kaakaji, Tatsuo Morimura, Haruhiko Kikuchi, Juji Takeuchi, Gene H. Barnett
Preclinical trial of doxorubicin entrapped in sterically stabilized liposomes in dogs with spontaneously arising malignant tumors
D. M. Vail, Laura D. Kravis, A. James Cooley, Ruthanne Chun, E. Gregory MacEwen
The potential of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide]to circumvent three multidrug-resistance phenotypes in vitro
R. A. Davey, Gloria M. Su, Rebecca M. Hargrave, Rozelle M. Harvie, Bruce C. Baguley, Mary W. Davey
Modulation of glucuronidation of SN-38, the active metabolite of irinotecan, by valproic acid and phenobarbital
E. Gupta, Xiaolin Wang, Jacqueline Ramirez, M. J. Ratain
Superiority of cyclosporin A over PSC-833 in enhancement of VP-16 efficacy in murine tumors in vivo
L. M. Slater, Paula Sweet, Marie Stupecky, Kathyrn Osann
Ras oncogene-transformed and nontransformed cell populations are each heterogeneous but respond differently to the chemotherapeutic drug cytosine arabinoside (Ara-C)
D. E. Axelrod, Y. Gusev, John W. Gamel
DNA topoisomerase II-dependent cytotoxicity of alkylaminoanthraquinones and their N-oxides
P. J. Smith, Nicola J. Blunt, Rodwige Desnoyers, Yvonne Giles, Laurence H. Patterson
Incidence of objectively diagnosed thromboembolic disease in cancer patients undergoing cytotoxic chemotherapy and / or hormonal therapy
A. A. Shlebak, D. B. Smith
Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro
C. L. Erickson-Miller, Richard D. May, Joseph Tomaszewski, Blaire Osborn, Martin J. Murphy, John G. Page, Ralph E. Parchment